Literature DB >> 3221096

Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.

M E Cooper1, T J Allen, R C O'Brien, P A Macmillan, B Clarke, G Jerums, A E Doyle.   

Abstract

Streptozotocin (STZ) diabetes was induced in spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Body weight, blood pressure, renal function, glycaemic control and proteinuria were assessed monthly for 32 weeks. At 32 weeks, the animals were killed and glomerular basement membrane (GBM) thickness and fractional mesangial volume were measured. There was no significant difference in renal function between diabetic SHR and diabetic WKY. Diabetic SHR showed an earlier and larger rise in total proteinuria and urinary albumin excretion than diabetic WKY. Urinary albumin excretion was increased more than tenfold in diabetic SHR compared to diabetic WKY after 32 weeks of diabetes. GBM thickness was significantly increased in diabetic SHR compared with diabetic WKY. Both diabetic WKY and diabetic SHR showed mesangial expansion when compared to their nondiabetic counterparts. On the other hand, both hypertensive models showed increased glomerular volume, which was not influenced by the presence of diabetes. The diabetic SHR model has features of accelerated nephropathy, as evidenced by increased albuminuria and GBM thickness. This suggests that pre-existing hypertension may play an important role in the progression of diabetic renal disease.

Entities:  

Mesh:

Year:  1988        PMID: 3221096     DOI: 10.1097/00004872-198812000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

1.  Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats.

Authors:  Pérola D B Ribaldo; Denise S Souza; Subrata K Biswas; Karen Block; Jacqueline M Lopes de Faria; José B Lopes de Faria
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

2.  Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

Authors:  M D Oldfield; L A Bach; J M Forbes; D Nikolic-Paterson; A McRobert; V Thallas; R C Atkins; T Osicka; G Jerums; M E Cooper
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

Authors:  Anil K Bidani; Maria Picken; Rifat Hacioglu; Geoffrey Williamson; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-12

4.  Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.

Authors:  Tiffani N Slaughter; Adrienne Paige; Denisha Spires; Naoki Kojima; Patrick B Kyle; Michael R Garrett; Richard J Roman; Jan M Williams
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-07       Impact factor: 3.619

5.  Morphometric analysis of arteriolar diameters in experimental nephropathies: application of microvascular casts.

Authors:  K Kimura; A Tojo; S Nanba; H Matsuoka; T Sugimoto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.

Authors:  B J Davis; C I Johnston; L M Burrell; W C Burns; E Kubota; Z Cao; M E Cooper; T J Allen
Journal:  Diabetologia       Date:  2003-06-28       Impact factor: 10.122

7.  Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.

Authors:  Shannon M Harlan; Kathleen M Heinz-Taheny; John M Sullivan; Tao Wei; Hana E Baker; Dianna L Jaqua; Zhonghua Qi; Martin S Cramer; Tatiyana L Shiyanova; Matthew D Breyer; Josef G Heuer
Journal:  J Am Soc Nephrol       Date:  2017-10-23       Impact factor: 10.121

Review 8.  The management of diabetic proteinuria. Which antihypertensive agent?

Authors:  M E Cooper; A E Doyle
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

9.  The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.

Authors:  T Soulis-Liparota; M E Cooper; M Dunlop; G Jerums
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

10.  Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.

Authors:  Tomoki Kosugi; Marcelo Heinig; Takahiro Nakayama; Thomas Connor; Yukio Yuzawa; Qiuhong Li; William W Hauswirth; Maria B Grant; Byron P Croker; Martha Campbell-Thompson; Li Zhang; Mark A Atkinson; Mark S Segal; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.